Coagulation defects in acute promyelocytic leukemia.
D000328:Adult; D000347:Afibrinogenemia / Q000150:complications; D001778:Blood Coagulation Disorders / Q000150:complications* / Q000188:drug therapy; D001792:Blood Platelets / Q000032:analysis; D001856:Bone Marrow Examination; D005164:Factor IX / Q000032:analysis; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005169:Factor VIII / Q000032:analysis; D005170:Factor X / Q000032:analysis; D005172:Factor XI / Q000032:analysis; D005174:Factor XII / Q000032:analysis; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010958:Plasminogen / Q000032:analysis; D011517:Prothrombin Time
D005165:Factor V; D005167:Factor VII; D005169:Factor VIII; D005164:Factor IX; D005170:Factor X; D005174:Factor XII; D005340:Fibrinogen; D010958:Plasminogen; D006493:Heparin; D005172:Factor XI